Most just lately, it's been discovered that conolidine and the above derivatives act within the atypical chemokine receptor 3 (ACKR3. Expressed in identical parts as classical opioid receptors, it binds to a big selection of endogenous opioids. Not like most opioid receptors, this receptor functions to be a scavenger and doesn't activate a next mes